VANCOUVER, British Columbia-- (BUSINESS WIRE)--Life Sciences BC (LSBC) is proud to announce the companies selected for its ...
WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has ...
TUKYSA in combination with trastuzumab and pertuzumab showed more than 50% improvement in median progression-free survival, ...
Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange ...
Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to ...
Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will ...
Three-year data demonstrate sustained improvements in corneal shape, meaningful visual acuity gains, and a favorable ...
Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S.
Founded by serial entrepreneur and CEO, Yann Fleureau, and former AI research leader at Novartis and Owkin Eric Durand, ...
Transcriptome-scale target biology and AI-driven automated chemistry produced a validated lead candidate in weeks, against an ...
Available online at chairsidemagazine.com and mailing to more than 100,000 dental practitioners nationwide, the free clinical ...
In this episode of Denatured, you’ll hear from Jennifer McMahon, partner at Seroba and Joey Mason, venture partner at Claret ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results